Roche and Genentech — Recursion AI drug discovery collaboration (2021)

Recursion supplies machine learning and experimental biology capabilities for neuroscience and oncology discovery. The upfront payment excludes contingent milestones and royalties.

Enterprise Healthcare & life sciences

Verified

Announced
7 Dec 2021 1

Read the source Compare with related

Contract facts

Source per value
DateDate the contract, order or partnership was announced or agreed, as stated in the cited source (YYYY-MM-DD). Empty when the source gives only a month or a year.
2021-12-071
BuyerThe purchasing organisation or named customer.
Roche and Genentech1
VendorThe contracting supplier or AI provider, as named in the source.
Recursion1
SectorGovernment for public-sector buyers (defence, intelligence, civil agencies, health services); Enterprise for companies.
Enterprise
Upfront payment $Upfront payment stated for research and licence collaborations.
$150,000,0001
Product or programThe AI product, model, platform or program supplied.
Recursion Operating System1

Sources

  1. ir.recursion.com accessed 2026-11-11

Dollar figures are stated in the source’s own currency and are not converted. Read the summary for what a figure covers.

Related contracts

All 87 contracts
  1. Undisclosed
  2. Undisclosed
  3. Eli Lilly — Isomorphic Labs AI discovery collaboration (2024)

    Eli Lilly and Company · Isomorphic Labs

    Undisclosed
  4. Undisclosed
  5. Undisclosed

Spot a change?

Amendment, renewal or a figure that moved? Email hello@aicontractstracker.com with the source link and we update this row and its verified date.